Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases

Frontiers in Microbiology

Volumn 6, Issue JUN, 2015, Pages

  Varankovich, Natallia V ^a   Nickerson, Michael T ^a   Korber, Darren R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antibiotic resistance; Gastrointestinal disorders; Gut microbiota; Human gut; Probiotic

Indexed keywords

AMINOGLYCOSIDE; BACTERIOCIN; CEPHALOSPORIN; MACROLIDE; PEDIOCIN; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AKKERMANSIA MUCINIPHILA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIUM; BIFIDOBACTERIUM; DRUG EFFICACY; ECOLOGY; ECOSYSTEM; FAECALIBACTERIUM PRAUSNITZII; GASTROINTESTINAL DISEASE; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; LACTIC ACID BACTERIUM; META ANALYSIS (TOPIC); NONHUMAN; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; YEAST;

BACTERIA (MICROORGANISMS);

EID: 84937002409     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00685     Document Type: Article

References (169)

1. Aiba, Y., Suzuki, N., Kabir, A.M., Takagi, A., and Koga, Y. (1998). Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 93, 2097-2101.
2. Alfaleh, K., Anabrees, J., Bassler, D., and Al-Kharfi, T. (2011). Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. doi: 10.1002/14651858.CD005496.pub3.
3. Armuzzi, A., Cremonini, F., Bartolozzi, F., Canducci, F., Candelli, M., Ojetti, V. et al. (2001). The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 15, 163-169.
4. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R. et al. (2013). Enterotypes of the human gut microbiome. Nature 473, 174-180.
5. Arvola, T., Laiho, K., Torkkeli, S., Mykkanen, H., Salminen, S., Maunula, L. et al. (1999). Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 104, e64.
6. Asahara, T., Nomoto, K., Shimizu, K., Watanuki, M., and Tanaka, R. (2001). Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J Appl Microbiol 91, 985-996.
7. Asahara, T., Shimizu, K., Nomoto, K., Asahara, T., Shimizu, K., and Nomoto, K. (2004). Probiotic Bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157: H7. Inf Imm 72, 2240-7.
8. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. (2013). Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 500, 232-236.
9. Aureli, P., Capurso, L., Castellazzi, A. M., Clerici, M., Giovannini, M., Morelli, L. et al. (2011). Probiotics and health: an evidence-based review. Pharmacol Res 63, 366-76.
10. Basu, S., Paul, D.K., Ganguly, S., Chatterjee, M., and Chandra, P.K. (2009). Efficacy of high dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol 43, 208-213.
11. Bennett, P. M. (2008). Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153, S347-S357. doi: 10.1038/sj.bjp.0707607
12. Benyacoub, J., Czarnecki-Maulden, G.L., Cavadini, C., Sauthier, T., Anderson, R.E., Schiffrin, E.J. et al. (2003). Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 133, 1158-1162.
13. Bergogne-Bérézin, E. (2000). Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Ag 16, 521-526.
14. Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L., and Hudault, S. (1997). The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63, 2747- 2753.
15. Bertino, J., and Fish, D. (2000). The safety profile of the fluoroquinolones. Clin Ther 22, 798- 817.
16. Bhardwaj, A., Malik, R.K., and Chauhan, P. (2008). Functional and safety aspects of enterococci in dairy foods. Indian J Microbiol 48, 317-325.
17. Bhinder, G., Sham, H.P., Chan, J.M., Morampudi, V., Jacobson, K., and Vallance, B.A. (2013). The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis. J Vis Exp 72, e50222.
18. Biavasco, F., Vignaroli, C., Lupidi, R., Manso, E., Facinelli, B., and Varaldo, P.E. (1997). In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide. Antimicrob Agents Chemother 41, 2165-2172.
19. Biavati, B. (1994). Degradation of complex carbohydrates. Int J Food Microb 24, 199-210.
20. Bibiloni, R., Fedorak, R.N., Tannock, G.W., Madsen, K.L., Gionchetti, P., Campieri, M. et al. (2005). VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100, 1539-1546.
21. Black, F.T., Andersen, P.L., Ørskov, J., Ørskov, F., Gaarslev, K. et al. (1989). Prophylactic efficacy of lactobacilli on traveler's diarrhea. Trav Med 7, 333-335.
22. Borenstein, D., McBee, M.E., and Schauer, D.B. (2008). Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Op Gastroenterol 24, 32-37.
23. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G. et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108, 16050- 16055.
24. Buydens, P., and Debeuckelaere, S. (1996). Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial. Scand J Gastroenterol 31, 887-891.
25. Caballero-Franco, C., Keller, K., De Simone, C., and Chadee, K. (2007). The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol -Gastroint Liver Physiol 292, 315-322.
26. Canducci, F., Cremonini, F., Armuzzi, A., Di Caro, S., Gabrielli, M., Santarelli, L. et al. (2002). Probiotics and Helicobacter pylori eradication. Digest Liver Dis 34, S81-S83.
27. Cebrián, R., Baños, A., Valdivia, E., Pérez-Pulido, R., Martínez-Bueno, M., and Maqueda, M. (2012). Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain. Food Microbiology 30, 59-67.
28. Charteris, W.P., Kelly, P.M., Morelli, L., and Collins, J.K. (1998). Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot 61, 1636-1643.
29. Chen, C.-C., Louie, S., Shi, H.N., and Walker, W.A. (2005). Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res 58, 1185-1191.
30. Chen, L.-S., Ma, Y., Maubois, J.-L., He, S.-H., Chen, L.-J., and Li, H.-M. (2010). Screening for the potential probiotic yeast strains from raw milk to assimilate cholesterol. Dairy Sci Technol 90, 537-548.
31. Choi, C.H., Jo, S.Y., Park, H.J., Chang, S.K., Byeon, J.S., and Myung, S.J. (2011). A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 45, 679-83.
32. Collado, M.C., Meriluoto, J., and Salminen, S. (2007). Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol 45, 454-460.
33. Cook, M.T., Tzortzis, G., Charalampopoulos, D., and Khutoryanskiy, V.V. (2012). Microencapsulation of probiotics for gastrointestinal delivery. J Control Release 162, 56- 67. doi:10.1016/j.jconrel.2012.06.003.
34. Cruchet, S., Obregon, M.C., Salazar, G., Diaz, E., and Gotteland, M. (2003). Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19, 716-721.
35. Cunha, B. A. (2001). Antibiotic therapy, Part II. Introduction. Med Clin North Am 85, 149-85.
36. Danielsen, M., and Wind, A. (2003). Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J Food Microbiol 82, 1-11.
37. Derrien, M., Vaughan, E. E., Plugge, C. M., and de Vos, W. M. (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54, 1469-1476.
38. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., and Dinan, T. G. (2008). The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 43, 164-174.
39. Devirgiliis, C., Coppola, D., Barile, S., Colonna, B., and Perozzi G. (2009). Characterization of the Tn916 conjugative transposon in a food-borne strain of Lactobacillus paracasei. Appl Environ Microbiol 75, 3866-71.
40. Di Bella, J.M., Bao, Y., Gloor, G.B., Burton, J.P., and Reid, G. (2013). High throughput sequencing methods and analysis for microbiome research. J Microbiol Methods 95, 401- 414.
41. DiBaise, J.K., Frank, D.N., and Mathur, R. (2012). Impact of the gut microbiota on the development of obesity: current concepts. Am J Gastroenterol Suppl 1, 22-27.
42. Dinan, T.G., Stanton, C., and Cryan, J.F. (2013). Psychobiotics: a novel class of psychotropic. Biol Psych 74, 720-6.
43. Dinleyici, E.C., Eren, M., Ozen, M., Yargic, Z.A., and Vandenplas, Y. (2012). Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther, 12, 395-410.
44. Doré, J., and Corthier, G. (2010). The human intestinal microbiota. Gastroentérol Clin Biolog 34, S7-S15.
45. Duca, F., Sakar, Y., Lepage, P., Devime, F., Langelier, B., Doré, J. et al. (2014). Replication of obesity and associated signaling pathways through transfer of microbiota from obese prone rats. Diabetes 63, 1624-36.
46. Dusko Ehrlich, S. and the MetaHIT Consortium. (2011). 'MetaHIT: The European Union Project on Metagenomics of the Human Intestinal Tract' in Metagenomics of the Human Body, ed. Nelson, K. (Springer Science+Business Media), Chapter 15.
47. Feld, L., Bielak, E., Hammer, K., and Wilcks, A. (2009). Characterization of a small erythromycin resistance plasmid pLFE1 from the food-isolate Lactobacillus plantarum M345. Plasmid 61, 159-70.
48. Flatley, E.A., Wilde, A.M., and Nailor, M.D. (2015). Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection. J Gastrointestin Liver Dis 24, 21-4. doi: 10.15403/jgld.2014.1121.fly
49. Flint, H.J., Scott, K.P., Duncan, S.H., Louis, P., and Forano, E. (2012). Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289-306.
50. Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J.-C. et al. (2007). A key role of dendritic cells in probiotic functionality. PLoS One 2, e313.
51. Foligné, B., Dewulf, J., Breton, J., Claisse, O., Lonvaud-Funel, A., and Pot, B. (2010). Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni. Int J Food Microbiol 140, 136-45.
52. Fooks, L. J., Fuller, R., and Gibson, G. R. (1999). Prebiotics, probiotics and human gut microbiology. Int Dairy J 9, 53-61.
53. Friedman, G. (2012). Preface: clinical applications of probiotics in gastroenterology: questions and answers. Gastroenterol Clin North Am 41, 763-79.
54. Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C., and Miller, L.E. (2010). Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 105, 1636-1641.
55. Gareau, M.G., Wine, E., Reardon, C., and Sherman, P. M. (2010). Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Inf Dis 201, 81-91.
56. Gbassi, G. K., and Vandamme, T. (2012). Probiotic encapsulation technology: from microencapsulation to release into the gut. Pharmaceutics 4, 149-163. doi:10.3390/pharmaceutics4010149.
57. Ge, Z., White, D. A., Whary, M. T., and Fox, J. G. (2001). Fluorogenic PCR-Based quantitative detection of a murine pathogen Helicobacter hepaticus. J Clin Microb 39, 2598-2602.
58. Gill, H. S., Shu, Q., Lin, H., Rutherfurd, K. J., and Cross, M. L. (2001). Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol 190, 97-9104.
59. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M., Brigidi, P. et al. (2003). Prophylactis of pouchitis onset with probiotic therapy: A double-blind, placebo controlled trial. Gastroenterol 124, 1202-1209.
60. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G. et al. (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterol 119, 305-309.
61. Gomes, A.M.P., and Malcata, F.X. (1999). Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci Tech 10, 139-157.
62. Guardabassi, L., and Courvalin, P. Antibiotics: Mode of action and mechanisms of resistance. In: Aarestrup F, Wegener HK (editors), Antimicrobial Resistance in Bacteria of Animal Origin. 2006; American Society for Microbiology, Washington DC, pp. 1-18.
63. Guerra, N.P., and Pastrana, L. (2002). Modelling the influence of pH on the kinetics of both nisin and pediocin production and characterization of their functional properties. Proc Biochem 37, 1005-1015.
64. Guglielmetti, S., Mora, D., Gschwender, M., and Popp, K. (2011). Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-a double-blind, placebo-controlled study. Alim Pharmacol Therapeu 33, 1123-1132.
65. Guo, X.H., Kim, J.M., Nam, H.M., Park, S.Y., and Kim, J.M. (2010). Screening lactic acid bacteria from swine origins for multistrain probiotics based on in vitro functional properties. Anaerobe 16, 321-326.
66. Guslandi, M., Giollo, P., and Testoni, P. A. (2003). A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15, 697-8.
67. Guslandi, M., Mezzi, G., Sorghi, M., and Testoni, P. A. (2000). Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45, 1462-4.
68. Hamilton-Miller, J.M.T. (2003). The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Ag, 22, 360-366.
69. Hayashi, A., Sato, T., Kamada, N., Mikami, Y., Matsuoka, K., and Hisamatsu, T. (2013). A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe 13, 711-22.
70. Hempel, S., Maher, A.R., Wang, Z., Miles, J. N. V., Shanman, R., Johnsen, B. et al. (2012). Probiotics for the prevention and treatment of antibiotic-associated diarrhea. A systematic review and meta-analysis. J Am Med Assoc 307, 1959-69.
71. Hill, C., Guarner, F., Reid., G., Gibson, G. R., Merenstein, D. J., Pot, B. et al. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Rev Gastroenterol Hepatol 11, 506-514. doi:10.1038/nrgastro.2014.66
72. Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M., and Flint, H. J. (2003). Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69, 4320-4324.
73. Holzapfel, W. H., and Schillinger U. (2002). Introduction to pre- and probiotics. Food Res Int 35, 109-116.
74. Huang, J.S., Bousvaros, A., Lee, J.W., Diaz, A., and Davidson, E.J. (2002). Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Diges Dis Sci 47, 2625-34.
75. Jernberg, C., Löfmark, S., Edlund, C., and Jansson, J. K. (2010). Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology (Reading, England), 156(Pt 11), 3216-23.
76. Jonganurakkun, B., Wang, Q., Xu, S. H., Tada, Y., Minamida, K., Yasokawa, D. et al. (2008). Pediococcus pentosaceus NB-17 for probiotic use. J Biosci Bioeng 106, 69-73.
77. Jungersen, M., Wind, A., Johansen, E., Christensen, J., Stuer-Lauridsen, B., and Eskesen, D. (2014). The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms 2, 92-110.
78. Kaier, K. (2012). Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections. Val Health 15, 87-93.
79. Karami, N., Martner, A., Enne, V. I., Swerkersson, S., Adlerberth, I., and Wold, A. E. (2007). Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J Antimicrob Chemother 60, 1142- 5. doi:10.1093/jac/dkm327.
80. Kararli, T. T. (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16, 351-380.
81. Karlsson, C.L., Onnerfält, J., Xu, J., Molin, G., Ahrné, S., and Thorngren-Jerneck., K. (2012) The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 20, 2257-2261.
82. Kelesidis, T., and Pothoulakis, C. (2012). Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeu Adv Gastroenterol 5, 111-25.
83. Kelly, C.P., Pothoulakis, C., and Lamont, J.T. (1994). Clostridium difficile colitis. N Engl J Med 330, 257-262.
84. Khan, N.H., Korber, D.R., Low, N.H., and Nickerson, M.T. (2013). Development of extrusion based legume protein isolate-alginate capsules for the protection and delivery of the acid sensitive probiotic, Bifidobacterium adolescentis. Food Res Int 54, 730-737. doi:10.1016/j.foodres.2013.08.017.
85. Kheadr, E., Bernoussi, N., Lacroix, C., and Fliss, I. (2004). Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. Int Dairy J 14, 1041-1053.
86. Klemmer, K.J., Korber, D.R., Low, N.H., and Nickerson, M.T. (2011). Pea protein-based capsules for probiotic and prebiotic delivery. Int J Food Sci Tech 46, 2248-2256.
87. Konieczna, P., Ferstl, R., Ziegler, M., Frei, R., Nehrbass, D., Lauener, R. P. et al. (2013). Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms. PloS One 8, e62617.
88. Kotikalapudi, B.L., Low, N.H., Nickerson, M.T., and Korber, D.R. (2010). In vitro characterization of probiotic survival, adherence and antimicrobial resistance: Candidate selection for encapsulation in a pea protein isolate-alginate delivery system. Int J Probiotics Prebiotics 5, 1-12.
89. Kotzampassi, K., and Giamarellos-Bourboulis, E. J. (2012). Probiotics for infectious diseases: more drugs, less dietary supplementation. Int J Antimicrob Agents 40, 288-296.
90. Kumura, H., Tanoue, Y., Tsukahara, M., Tanaka, T., and Shimazaki, K. (2004). Screening of dairy yeast strains for probiotic applications. J Dairy Sci 87, 4050-6.
91. Kurugol, Z., and Koturoglu, G. (2005). Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94, 44-47.
92. Lee, D. K., Park, S. Y., An, H. M., Kim, J. R., Kim, M. J., Lee, S. W. et al. (2011). Antimicrobial activity of Bifidobacterium spp. isolated from healthy adult Koreans against cariogenic microflora. Arch Oral Biol 56, 1047-54. doi:10.1016/j.archoralbio.2011.03.002.
93. Lee, J.-Y., Chu, S.-H., Jeon, J. Y., Lee, M.-K., Park, J.-H., Lee, D.-C. et al. (2014a). Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial. Digest Liver Dis 46, 1126-1132. doi:10.1016/j.dld.2014.09.004
94. Lee, D. K., Park, J. E., Kim, M. J., Seo, J. G., Lee, J. H., and Ha, N. J. (2014b). Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clin Res Hepatol Gastroenterol. In Press. doi:10.1016/j.clinre.2014.09.006.
95. Lim, P. L., Toh, M., and Liu, S. Q. (2015). Saccharomyces cerevisiae EC-1118 enhances the survivability of probiotic Lactobacillus rhamnosus HN001 in an acidic environment. Appl Microbiol Biotechnol 2015 Apr 7. [Epub ahead of print]
96. Ling, Z., Liu, X., Cheng, Y., Luo, Y., Yuan, L., Li, L., and Xiang, C. (2015). Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea. Biomed Res Int 2015:582048. doi: 10.1155/2015/582048. [Epub ahead of print]
97. Lollo, P. C. B., Cruz, G., Morato, P. N., Moura, C. S., Carvalho-Silva, L. B., Oliveira, C. F. et al. (2012). Probiotic cheese attenuates exercise-induced immune suppression in Wistar rats. J Dairy Sci 95, 3549-58.
98. Macfarlane, G. T., and Macfarlane, S. (2011). Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 45, S120-S127.
99. Mackos, A.R., Eubank, T.D., Parry, N.M.A., and Bailey, M.T. (2013). Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection. Infect Immun 81, 3253-3263.
100. Mangin, I., Bouhnik, Y., Bisetti, N., and Decaris, B. (1999). Molecular monitoring of human intestinal Bifidobacterium strain diversity. Res Microbiol 150, 343-350.
101. Mårtensson, O., Biörklund, M., Lambo, A. M., Dueñas-Chasco, M., Irastorza, A., Holst, O. et al. (2005). Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans. Nutr Res 25, 429-442.
102. McFarland, L.V., Surawicz, C.M., Greenberg, R.N., Fekety, R., Elmer, G.W., Moyer, K.A. et al. (1994). A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc 271, 1913-8.
103. McFarland, L. V. (2007). Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 5, 97-105.
104. McFarland, L. V. (2009). Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe 15, 274-280.
105. Mikelsaar, M. (2011). Human microbial ecology: Lactobacilli, probiotics, selective decontamination. Anaerobe 17, 463-467.
106. Shin, N. R., Lee, J. C., Lee, H. Y., Kim, M. S., Whon, T. W., Lee, M. S., et al. (2014). An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735.
107. Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R. et al. (2014). Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 26, 1155-62.
108. Ndegwa, S., and Nkansah, E. (2008). Vancomycin for C. difficile pseudomembranous colitis: guidelines and a clinical effectiveness review. Ottawa, ON, CAN: Canadian Agency for Drugs and Technologies in Health, 2008.
109. NIH HMP Working Group, Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L. et al. (2009). The NIH Human Microbiome Project. Genome Res 19, 2317-23.
110. Nikfar, S., Rahimi, R., Rahimi, F., Derakhshani, S., and Abdollahi, M. (2008). Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 5, 1775-80.
111. Omar, J.M., Chan, Y., Jones, M.L., Prakash, S., and Jones, P.J.H. (2013). Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons. J Funct Foods 5, 116-123.
112. Osmanagaoglu, O., Kiran, F., and Ataoglu, H. (2010). Evaluation of in vitro probiotic potential of Pediococcus pentosaceus OZF Isolated from human breast milk. Probiotics Antimicrobl Prot 2, 162-174.
113. Owen, L., Reinders, M., Narramore, R., Marsh, A. M. R., Gar Lui, F., Baron, R. et al. (2014). A double blind, placebo controlled, randomised pilot trial examining the effects of probiotic administration on mood and cognitive function. Proceed Nutr Soc 73(OCE1), e29.
114. Pawlowski, S.W., Calabrese, G., Kolling, G.L., Freire, R., Alcantara Warren, C., Liu, B. et al. (2010). Murine Model of Clostridium difficile infection with aged gnotobiotic C57BL/6 Mice and a BI/NAP1 strain. J Infect Dis 202, 1708-1712.
115. Pepin, J., Valiquette, L., Alary, M.E., Villemure, P., Pelletier, A., Forget, K. et al. (2004). Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171, 466-72.
116. Pepin, J., Valiquette, L., and Cossette, B. (2005). Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173, 1037-1042.
117. Pflughoeft, K.J., and Versalovic, J. (2012). Human microbiome in health and disease. Ann Rev Pathol 7, 99-122.
118. Pieniz, S., Andreazza, R., Anghinoni, T., Camargo, F., and Brandelli, A. (2014). Probiotic potential, antimicrobial and antioxidant activities of Enterococcus durans strain LAB18s. Food Control 37, 251-256.
119. Pitkala, K.H., Strandberg, T.E., Finne Soveri, U.H., Ouwehand, A.C., Poussa, T., and Salminen, S. (2007). Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. J Nutr Health Ag 11, 305-311.
120. Psani, M., and Kotzekidou, P. (2006). Technological characteristics of yeast strains and their potential as starter adjuncts in Greek-style black olive fermentation. World J Microbiol Biotechnol 22, 1329-1336.
121. Raccach, M. (2014). 'Pediococcus' in Encyclopedia of Food Microbiology, ed. Batt, C.A., Tortorello, M.L. 2nd Revised Edition. (Academic Press Inc.), 1-5.
122. Radulovic, Z., Petrovic, T., and Bulajic, S. (2012). Antibiotic Susceptibility of Probiotic Bacteria, Antibiotic Resistant Bacteria-A Continuous Challenge in the New Millennium, Dr. Marina Pana (Ed.), 550-576. University of Belgrade, Faculty of Agriculture, Republic of Serbia. doi: 10.5772/28915
123. Rehaiem, A., Belgacem, Z. Ben, Edalatian, M. R., Martínez, B., Rodríguez, A., Manai, M. et al. (2014). Assessment of potential probiotic properties and multiple bacteriocin encoding genes of the technological performing strain Enterococcus faecium MMRA. Food Control 37, 343-350.
124. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria (October 2001). "Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria". Food and Agriculture Organization of the United Nations, World Health Organization.
125. Rubinstein, E. (2001). Comparative safety of the different macrolides. Int J Antimicrob Agents 18 Suppl 1, 71-76.
126. Samanta, M., Sarkar, M., Ghosh, P., Ghosh, J.K., Sinha, M.K., and Chatterjee, S. (2009). Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 55, 128-131.
127. Sanz, Y. (2007). Ecological and functional implications of the acid-adaptation ability of Bifidobacterium: A way of selecting improved probiotic strains. Int Dairy J 17, 1284- 1289.
128. Sapkota, A.R., Lefferts, L.Y., Mckenzie, S., and Walker, P. (2007). What do we feed to food production animals? A review of animal feed ingredients and their potential impacts on human health. Environ Health Perspect 115, 663-670.
129. Sarker, S.A., Sultana, S., Fuchs, G.J., Alam, N.H., Azim, T., Brüssow, H. et al. (2005). Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116, e221-8.
130. Scharek, L., Hartmann, L., Heinevetter, L., and Blaut, M. (2000). Bifidobacterium adolescentis modulates the specific immune response to another human gut bacterium, Bacteroides thetaiotaomicron, in gnotobiotic rats. Immunobiol 202, 429-441.
131. Shan, L. S., Hou, P., Wang, Z. J., Liu, F. R., Chen, N., Shu, L.H. et al. (2013). Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 4, 329-34.
132. Sharma, S., Chaturvedi, J., Chaudhari, B.P., Singh, R.L., and Kakkar, P. (2012). Probiotic Enterococcus lactis IITRHR1 protects against acetaminophen-induced hepatotoxicity. Nutrition 28, 173-181.
133. Shiba, T., Aiba, Y., Ishikawa, H., Ushiyama, A., Takagi, A., Mine, T. et al. (2003). The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol Immunol 47, 371-378.
134. Shimakawa, Y., Matsubara, S., Yuki, N., Ikeda, M., and Ishikawa, F. (2003). Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Int J Food Microbiol 81, 131-136.
135. Shirasawa, Y., Shibahara-Sone, H., Lino, T., and Ishikawa, F. (2010). Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. J Dairy Sci 93, 4526-4534.
136. Shornikova, A.V., Casas, I.A., Isolauri, E., Mykkanen, H., and Vesikari, T. (2008). Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Ped Gastroenterol Nutr 24, 399-404.
137. Sinn, D. H., Song, J. H., Kim, H. J., Lee, J. H., Son, H. J., Chang, D. K. et al. (2008). Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Digest Dis Sci 53, 2714-8.
138. Surawicz, C.M. (2003). Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 17, 775-783.
139. Surawicz, C.M., Mcfarland, L.V., Greenberg, R.N., Rubin, M., Fekety, R., Mulligan, M.E. et al. (2000). The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31, 1012-1017.
140. Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M., and Doerffel, Y. (2008). Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Infl Bowel Diseases 14, 147-161.
141. Szajewska, H., Ruszczynski, M., and Radzikowski, A. (2006). Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 149, 367-372.
142. Tambyah, P.A., Marx, J.A., and Maki, D.G. (2004). Nosocomial infection with vancomycin dependent enterococci. Emerg Infect Dis 10, 1277-1281.
143. Temmerman, R., Pot, B., Huys, G., and Swings, J. (2003). Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 81, 1-10.
144. Thygesen, J. B., Glerup, H., and Tarp, B. (2012). Saccharomyces boulardii fungemia caused by treatment with a probioticum. BMJ Case Rep 2012 doi: 10.1136/bcr.06.2011.4412.
145. Toomey, N., Monaghan, A., Fanning, S., and Bolton, D.J. (2009). Assessment of antimicrobial resistance transfer between lactic acid bacteria and potential foodborne pathogens using in vitro methods and mating in a food matrix. Foodborne Pathog Dis 6, 925-933.
146. Tsai, C.-C., Lai, C.-H., Yu, B., and Tsen, H.-Y. (2008). Use of specific primers based on the 16S-23S internal transcribed spacer (ITS) region for the screening Bifidobacterium adolescentis in yogurt products and human stool samples. Anaerobe 14, 219-223.
147. Tuohy, K.M., Conterno, L., Gasperotti, M., and Viola, R. (2012). Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J Agric Food Chem 60, 8776-8782.
148. Turpin, W., Humblot, C., Thomas, M., and Guyot, J.-P. (2010). Lactobacilli as multifaceted probiotics with poorly disclosed molecular mechanisms. Int J Food Microbiol 143, 87- 102.
149. Turroni, F., Van Sinderen, D., and Ventura, M. (2011). Genomics and ecological overview of the genus Bifidobacterium. Int J Food Microbiol 149, 37-44.
150. van Passel, M. W., Kant, R., Zoetendal, E. G., Plugge, C. M., Derrien, M., Malfatti, S. A. et al. (2011). The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 6, e16876.
151. Vanderhoof, J.A., Whitney, D.B., Antonson, D.L., Hanner, T.L., Lupo, J.V., and Young, R.J. (1999). Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135, 564-568.
152. Varankovich, N. V., Khan, N. H., Nickerson, M. T., Kalmokoff, M., and Korber, D. R. (2015). Evaluation of pea protein-polysaccharide matrices for encapsulation of acid-sensitive bacteria. Food Res Int 70, 118-124.
153. Ventura, M., O'Connell Motherway, M., Leahy, S., Moreno-Munoz, J.A., Fitzgerald Gerald, F., and van Sinderen, D. (2007). From bacterial genome to functionality; case Bifidobacteria. Int J Food Microbiol 120, 2-12.
154. Ventura, M., Turroni, F., Motherway, M.O.C., Macsharry, J., and Van Sinderen, D. (2012). Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends Microbiol 20, 467-476.
155. Verdú, E.F., Bercik, P., Huang, X.X., Lu, J., Al-Mutawaly, N., Sakai, H. et al. (2008). The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol 295, G664-70. doi: 10.1152/ajpgi.90316.2008.
156. Videlock, E.J., and Cremonini, F. (2012). Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 35, 1355-1369.
157. Wallace, T.C., Guarner, F., Madsen, K., Cabana, M.D., Gibson, G., Hentges, E. et al. (2011). Human gut microbiota and its relationship to health and disease. Nutr Rev 69, 392-403.
158. Wang, M., Molin, G., Ahrné, S., Adawi, D., and Jeppsson, B. (2007). High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes. Dig Dis Sci 52, 620-627.
159. Wang, J., Korber, D. R., Low, N. H., and Nickerson, M. T. (2015). Encapsulation of Bifidobacterium adolescentis with legume proteins and its survival under stimulated gastric conditions and during storage within commercial fruit juices. Food Sci Biotechnol 24, 383-391.
160. Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher E. et al. (2015). Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet fed mice. ISME J 9, 1-15. doi:10.1038/ismej.2014.99
161. Wei, Y.-X., Zhang, Z.-Y., Liu, C., Malakar, P.K., and Guo, X.-K. (2012). Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences. World J Gastroenterol 18, 479-488.
162. Wen, K., Li, G., Bui, T., Liu, F., Li, Y., Kocher, J. et al. (2012). High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30, 1198-1207.
163. Werner, G., Coque, T.M., Hammerum, A.M., Hope, R., Hryniewicz, W., Johnson, A. et al. (2008). Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13.
164. Whorwell, P.J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'mahony, L. et al. (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101, 1581-1590.
165. Wood, K. A. (2010). Synbiot production and encapsulation. (M.Sc. Thesis) Saskatoon, SK: University of Saskatchewan.
166. Wozniak, R. A., and Waldor, M. K. (2010). Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat Rev Microbiol 8, 552-63.
167. Wrzosek, L. M. S., Noordine, M. L., Bouet, S., Joncquel Chevalier-Curt, M., Robert, V., Philippe, C. et al. (2013). Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biology 2013:11. doi: 10.1186/1741-7007-11-61
168. Wunderlich, P.F., Braun, L., Fumagalli, I., D'Apuzzo, V., Heim, F., Karly, M. et al. (1989). Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 17, 333-338.
169. Yamaguchi, T., Miura, Y., and Matsumoto, T. (2013). Antimicrobial susceptibility of Enterococcus strains used in clinical practice as probiotics. J Infect Chemother 19, 1109- 15.